SynOx Advances $75M Phase 3 Trial for Rare Tumor Treatment
Could SynOx's $75M Phase 3 Trial Be the Next Big Leap in TGCT Treatment?
Source: biopharma-reporter.com
Bioqube Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bioqube Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bioqube Ventures Today - Breaking & Trending Today
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/FWDFOT2RX5EVRHSHQ64VJBQU7Q.jpg)
SynOx Therapeutics raises $75m in fresh funding round
Iirsh and UK firm has raised more than $100 million to date
Source: irishtimes.com
Biopharma firm SynOx Therapeutics raises $75m in funding round
Biopharmaceutical company SynOx Therapeutics has raised $75m (€70.5m) to continue its development of a treatment for Tenosynovial Giant Cell Tumour (TGCT).
Source: independent.ie
Bicara Therapeutics Raises $165M in Series C Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Anavo Therapeutics extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic
Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase biology, announced today an EUR 8.5 million seed round extension, adding MRL Ventures Fund as a
Source: finanznachrichten.de